{"id":51132,"topic":"peptides","source":"Drug Discovery News","title":"FDA panel backs unapproved peptides despite safety concerns - Drug Discovery News","url":"https://www.drugdiscoverynews.com/fda-panel-backs-unapproved-peptides-despite-safety-concerns-17408","url_hash":"962fd5eb55226ec752100d6c1795093cf3268038","author":"","summary":"<a href=\"https://news.google.com/rss/articles/CBMioAFBVV95cUxPbWJjS1A1clZmWFBkeVB0YkhuQXBoNGtubFc2TlRUUUhRcktiX0w5OGFiWWlndkVBejZ5ZzZiVi1OdGZmZGhfc05fVVJPUXl2djlZWVRXYXA5TVc5ZW0wMnZhdERHOUNzNGtMWmhDUm9HV0UtVHZJQnZLTGkzbVFDcVVtZXBWRTNjR2NIWWg1VFZkVnp3Y3Jza1NzUDk3Ykt5?oc=5\" target=\"_blank\">FDA panel backs unapproved peptides despite safety concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Drug Discovery News</font>","content":"JavaScript is disabled\nIn order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.","image_url":null,"lang":"en","published_at":"2026-08-01T01:06:08+00:00","fetched_at":"2026-08-01T05:15:08+00:00","status":"read","starred":0,"extract_state":"ok","summary_auto":"JavaScript is disabled\nIn order to continue, we need to verify that you're not a robot.","cluster_id":null,"extract_retries":0,"extract_error":null,"contract_version":"news_item.v1","format_contract_version":"news_item_formats.v1","dedup_url":"https://www.drugdiscoverynews.com/fda-panel-backs-unapproved-peptides-despite-safety-concerns-17408","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"medium","confidence":0.75,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"Medium confidence: short full text extraction produced 157 characters.","operator_guidance":{"severity":"info","recommended_action":"review_short_text","next_step":"Review the short extracted text before using it as a source.","operator_label":"Short text","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"partial_text","label":"Partial text","has_full_text":true,"has_summary":true,"content_length":157,"summary_length":87,"usable_text_length":157,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":157,"summary_length":87}},"news_item":{"id":51132,"canonical_url":"https://www.drugdiscoverynews.com/fda-panel-backs-unapproved-peptides-despite-safety-concerns-17408","source_url":"https://www.drugdiscoverynews.com/fda-panel-backs-unapproved-peptides-despite-safety-concerns-17408","title":"FDA panel backs unapproved peptides despite safety concerns - Drug Discovery News","source_name":"Drug Discovery News","author":null,"published_at":"2026-08-01T01:06:08+00:00","locale":"en","topic":"peptides","tags":[],"rss_summary":"<a href=\"https://news.google.com/rss/articles/CBMioAFBVV95cUxPbWJjS1A1clZmWFBkeVB0YkhuQXBoNGtubFc2TlRUUUhRcktiX0w5OGFiWWlndkVBejZ5ZzZiVi1OdGZmZGhfc05fVVJPUXl2djlZWVRXYXA5TVc5ZW0wMnZhdERHOUNzNGtMWmhDUm9HV0UtVHZJQnZLTGkzbVFDcVVtZXBWRTNjR2NIWWg1VFZkVnp3Y3Jza1NzUDk3Ykt5?oc=5\" target=\"_blank\">FDA panel backs unapproved peptides despite safety concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Drug Discovery News</font>","full_text":"JavaScript is disabled\nIn order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.","excerpt":"JavaScript is disabled\nIn order to continue, we need to verify that you're not a robot.","extraction":{"state":"ok","confidence":0.75,"error":null,"explanation":"Medium confidence: short full text extraction produced 157 characters.","diagnostics_url":"/api/diagnose?url=https%3A//www.drugdiscoverynews.com/fda-panel-backs-unapproved-peptides-despite-safety-concerns-17408","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"medium","confidence":0.75,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"Medium confidence: short full text extraction produced 157 characters.","operator_guidance":{"severity":"info","recommended_action":"review_short_text","next_step":"Review the short extracted text before using it as a source.","operator_label":"Short text","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"partial_text","label":"Partial text","has_full_text":true,"has_summary":true,"content_length":157,"summary_length":87,"usable_text_length":157,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":157,"summary_length":87}}},"display_formats":["compact","card","full","digest_section","json"]},"daily_stack_record":{"title":"FDA panel backs unapproved peptides despite safety concerns - Drug Discovery News","url":"https://www.drugdiscoverynews.com/fda-panel-backs-unapproved-peptides-despite-safety-concerns-17408","summary":"JavaScript is disabled\nIn order to continue, we need to verify that you're not a robot.","source":"Drug Discovery News","date":"2026-08-01T01:06:08+00:00","content":"JavaScript is disabled\nIn order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.","confidence":0.75,"diagnostics_url":"/api/diagnose?url=https%3A//www.drugdiscoverynews.com/fda-panel-backs-unapproved-peptides-despite-safety-concerns-17408","quality_bucket":"medium","failure_kind":"none","retryable":false,"quality_reason":"Medium confidence: short full text extraction produced 157 characters.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"medium","confidence":0.75,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"Medium confidence: short full text extraction produced 157 characters.","operator_guidance":{"severity":"info","recommended_action":"review_short_text","next_step":"Review the short extracted text before using it as a source.","operator_label":"Short text","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"partial_text","label":"Partial text","has_full_text":true,"has_summary":true,"content_length":157,"summary_length":87,"usable_text_length":157,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":157,"summary_length":87}},"tags":[]},"fallback_formats":["markdown","json","html"],"actions":{"read":"/item/51132","export_markdown":"/api/items/51132/export?format=markdown","export_json":"/api/items/51132/export?format=json","diagnose":"/api/diagnose?url=https%3A//www.drugdiscoverynews.com/fda-panel-backs-unapproved-peptides-despite-safety-concerns-17408"},"formats":{"full":{"id":51132,"title":"FDA panel backs unapproved peptides despite safety concerns - Drug Discovery News","url":"https://www.drugdiscoverynews.com/fda-panel-backs-unapproved-peptides-despite-safety-concerns-17408","source":"Drug Discovery News","author":null,"published_at":"2026-08-01T01:06:08+00:00","locale":"en","topic":"peptides","tags":[],"excerpt":"JavaScript is disabled\nIn order to continue, we need to verify that you're not a robot.","full_text":"JavaScript is disabled\nIn order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.","reading_time_min":1,"extraction":{"state":"ok","confidence":0.75,"error":null,"explanation":"Medium confidence: short full text extraction produced 157 characters.","diagnostics_url":"/api/diagnose?url=https%3A//www.drugdiscoverynews.com/fda-panel-backs-unapproved-peptides-despite-safety-concerns-17408","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"medium","confidence":0.75,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"Medium confidence: short full text extraction produced 157 characters.","operator_guidance":{"severity":"info","recommended_action":"review_short_text","next_step":"Review the short extracted text before using it as a source.","operator_label":"Short text","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"partial_text","label":"Partial text","has_full_text":true,"has_summary":true,"content_length":157,"summary_length":87,"usable_text_length":157,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":157,"summary_length":87}}},"quality_profile":{"profile_version":"extraction_quality.v2","bucket":"medium","confidence":0.75,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"Medium confidence: short full text extraction produced 157 characters.","operator_guidance":{"severity":"info","recommended_action":"review_short_text","next_step":"Review the short extracted text before using it as a source.","operator_label":"Short text","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"partial_text","label":"Partial text","has_full_text":true,"has_summary":true,"content_length":157,"summary_length":87,"usable_text_length":157,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":157,"summary_length":87}},"actions":{"read":"/item/51132","export_markdown":"/api/items/51132/export?format=markdown","export_json":"/api/items/51132/export?format=json","diagnose":"/api/diagnose?url=https%3A//www.drugdiscoverynews.com/fda-panel-backs-unapproved-peptides-despite-safety-concerns-17408"}},"digest":{"id":51132,"title":"FDA panel backs unapproved peptides despite safety concerns - Drug Discovery News","url":"https://www.drugdiscoverynews.com/fda-panel-backs-unapproved-peptides-despite-safety-concerns-17408","source":"Drug Discovery News","topic":"peptides","published_at":"2026-08-01T01:06:08+00:00","excerpt":"JavaScript is disabled In order to continue, we need to verify that you're not a robot.","quality_bucket":"medium","quality_reason":"Medium confidence: short full text extraction produced 157 characters.","reading_time_min":1,"cluster_id":null},"card":{"display_title":"FDA panel backs unapproved peptides despite safety concerns - Drug Discovery News","subtitle":"Drug Discovery News · 2026-08-01","summary":"JavaScript is disabled In order to continue, we need to verify that you're not a robot.","badges":["quality:medium"],"links":{"read":"/item/51132","original":"https://www.drugdiscoverynews.com/fda-panel-backs-unapproved-peptides-despite-safety-concerns-17408","diagnose":"/api/diagnose?url=https%3A//www.drugdiscoverynews.com/fda-panel-backs-unapproved-peptides-despite-safety-concerns-17408"},"quality_warning":null},"export":{"title":"FDA panel backs unapproved peptides despite safety concerns - Drug Discovery News","url":"https://www.drugdiscoverynews.com/fda-panel-backs-unapproved-peptides-despite-safety-concerns-17408","summary":"JavaScript is disabled\nIn order to continue, we need to verify that you're not a robot.","source":"Drug Discovery News","date":"2026-08-01T01:06:08+00:00","content":"JavaScript is disabled\nIn order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.","confidence":0.75,"diagnostics_url":"/api/diagnose?url=https%3A//www.drugdiscoverynews.com/fda-panel-backs-unapproved-peptides-despite-safety-concerns-17408","quality_bucket":"medium","failure_kind":"none","retryable":false,"quality_reason":"Medium confidence: short full text extraction produced 157 characters.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"medium","confidence":0.75,"failure_kind":"none","retryable":false,"retry_after_attempts":0,"reason":"Medium confidence: short full text extraction produced 157 characters.","operator_guidance":{"severity":"info","recommended_action":"review_short_text","next_step":"Review the short extracted text before using it as a source.","operator_label":"Short text","can_retry":false,"can_use_summary":false,"diagnostics_required":false},"content_depth":{"contract_version":"content_depth.v1","category":"partial_text","label":"Partial text","has_full_text":true,"has_summary":true,"content_length":157,"summary_length":87,"usable_text_length":157,"source_field":"content"},"legacy_collapsed":false,"signals":{"extract_state":"ok","extract_error":null,"extract_retries":0,"content_length":157,"summary_length":87}},"tags":[],"format_contract_version":"news_item_formats.v1"}}}